Big pharma, Biotech, Partnering, Pharma

Cancer Genetics signs biotech deal with AstraZeneca

Posted on 10 June 2014

Tags: ,

Cancer Genetics has been selected by AstraZeneca for a biotech deal to provide biomarker-based diagnostic testing for cancer.

CGI will perform complex testing for diagnosis and prognosis of cancer patients in Central America and the Caribbean.

CGI will work in close conjunction with AZ on exploring expansion opportunities into additional geographic territories, further oncology categories, and into select oncology trials.

For further deal information visit Current Agreements (subscription required)


Browse: Complete Current Partnering report catalog

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply